Gulf Coast Regional Blood CenterSeptember 14, 2022

FDA 483 - Gulf Coast Regional Blood Center - September 14, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gulf Coast Regional Blood Center

Record Details

An FDA inspection of Gulf Coast Regional Blood Center in Houston, TX, revealed a significant issue regarding donor eligibility. The firm failed to properly defer a donor of blood and blood components, despite their own reference table indicating an indefinite deferral. This indicates a lapse in adherence to established donor screening protocols.

Company: Gulf Coast Regional Blood Center
Inspection Date: September 14, 2022
Product Type: Biologics
Office: Division of Human and Animal Food Operations - West III
People: Sunitha K. Rajaram (issuing_officer)
Bobbi Miller
Maira P. Brading (investigator)

Open in Dashboard

ID · b1fea2b7-61ec-46d6-ac20-bacb31a3e38b